KRYSTAL-1: Updated efficacy and safety of adagrasib (MRTX849) with or without cetuximab in patients with advanced colorectal cancer (CRC) harboring a KRASG12C mutation Meeting Abstract
| Authors: | Klempner, S. J.; Weiss, J.; Pelster, M.; Spira, A.; Barve, M.; Ou, S. H. I.; Leal, A.; Bekaii-Saab, T.; Christensen, J. G.; Kheoh, T.; Velastegui, K.; Torossian, H. D.; Yaeger, R. |
| Abstract Title: | KRYSTAL-1: Updated efficacy and safety of adagrasib (MRTX849) with or without cetuximab in patients with advanced colorectal cancer (CRC) harboring a KRASG12C mutation |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1391 |
| Language: | English |
| ACCESSION: | WOS:000866211602430 |
| DOI: | 10.1016/j.annonc.2022.08.020 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA24 -- Source: Wos |
